HEMATOLOGIC AND LYMPHOCYTIC DISORDER

Clinical trials for HEMATOLOGIC AND LYMPHOCYTIC DISORDER explained in plain language.

Never miss a new study

Get alerted when new HEMATOLOGIC AND LYMPHOCYTIC DISORDER trials appear

Sign up with your email to follow new studies for HEMATOLOGIC AND LYMPHOCYTIC DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 4 Completed 1 Terminated 1

New drug combo may reduce transplant complications in blood cancer patients

Disease control Completed

This study tested whether adding the drug itacitinib to standard medications (tacrolimus and sirolimus) could help prevent graft-versus-host disease (GVHD) in 59 people with blood cancers like leukemia or myelodysplastic syndrome who received a donor stem cell transplant. GVHD oc…

Matched conditions: HEMATOLOGIC AND LYMPHOCYTIC DISORDER

Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated May 17, 2026 03:43 UTC

HEMATOLOGIC AND LYMPHOCYTIC DISORDER

Get alerted when new HEMATOLOGIC AND LYMPHOCYTIC DISORDER trials appear

New drug combo may reduce transplant complications in blood cancer patients